Health care pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 health care pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- SAR 18.61T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | SAR 36.8B | SAR 243.36 | 1.88% down | 117% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | SAR 30.4B | SAR 438.12 | 1.88% down | 18% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | SAR 17.9B | SAR 318.20 | 1.01% up | 108% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | SAR 30.4B | SAR 465.20 | 2.47% down | 51% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | SAR 32.6B | SAR 1,166.19 | 1.87% up | 86% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | SAR 26.9B | SAR 193.03 | 0.27% up | 19% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | SAR 17B | SAR 102.10 | 0.62% down | 63% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | SAR 21.5B | SAR 1,076.31 | 3.94% down | 50% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | SAR 34.8B | SAR 366.21 | 3.77% down | 332% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | SAR 29.1B | SAR 173.22 | 1.43% down | 66% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | SAR 16.9B | SAR 154.43 | 0.48% down | 86% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | SAR 57.1B | SAR 293.25 | 0.22% up | 21% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | SAR 18.7B | SAR 53.34 | 3.34% up | 395% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | SAR 18.1B | SAR 104.05 | 0.25% down | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | SAR 23.4B | SAR 358.26 | 3.27% up | 34% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | SAR 17.4B | SAR 181.17 | 3.86% down | 45% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | SAR 24.8B | SAR 365.99 | 1.91% up | 255% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | SAR 18.3B | SAR 218.78 | 3.16% down | 21% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | SAR 34.6B | SAR 1,488.17 | 0.34% down | 27% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | SAR 56.9B | SAR 886.92 | 4.57% down | 41% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | SAR 26.7B | SAR 243.74 | 4.15% down | 10% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | SAR 23.1B | SAR 163.73 | 1.25% up | 13% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | SAR 19.7B | SAR 466.59 | 0.38% down | 231% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | SAR 44.6B | SAR 230.39 | 0.02% down | 17% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | SAR 15.1B | SAR 110.58 | 1.24% up | 168% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | SAR 49.3B | SAR 98.61 | 1.54% down | 26% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | SAR 118.9B | SAR 541.87 | 20.58% up | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | SAR 105.9B | SAR 146.14 | 0.59% up | 91% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | SAR 26.8B | SAR 508.94 | 1.25% up | 6% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | SAR 11.7B | SAR 60.39 | 0.92% down | 41% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | SAR 27.6B | SAR 350.85 | 1.59% down | 129% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | SAR 31.7B | SAR 39.65 | 0.67% up | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | SAR 26.5B | SAR 302.52 | 3.79% down | 32% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | SAR 63B | SAR 960.11 | 5.32% down | 29% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | SAR 89.3B | SAR 2,097.18 | 3.16% down | 22% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | SAR 123.1B | SAR 303.04 | 5.59% down | 26% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | SAR 74.3B | SAR 554.47 | 1.06% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | SAR 23B | SAR 566.48 | 3.33% down | 43% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | SAR 28B | SAR 80.23 | 2.24% down | 90% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | SAR 85.5B | SAR 74.57 | 1.97% down | 99% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | SAR 46.4B | SAR 55.63 | 1.00% down | 8% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | SAR 168.7B | SAR 144.56 | 8.74% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | SAR 588.8B | SAR 103.30 | 1.85% down | 15% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | SAR 447.3B | SAR 218.83 | 2.05% down | 30% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | SAR 146.1B | SAR 254.02 | 1.38% down | 79% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | SAR 358.3B | SAR 3,463.45 | 2.35% down | 28% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | SAR 495.2B | SAR 1,953.00 | 2.94% down | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | SAR 118.8B | SAR 192.61 | 0.75% up | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | SAR 171.3B | SAR 1,499.27 | 0.97% down | 16% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | SAR 674.8B | SAR 389.62 | 0.58% down | 16% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | SAR 1.23T | SAR 498.17 | 3.61% down | 45% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | SAR 1.88T | SAR 1,063.56 | 0.86% down | 25% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | SAR 20.9B | SAR 30.76 | 3.19% down | 0% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | SAR 642.6B | SAR 145.80 | 1.42% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | SAR 4.51T | SAR 5,068.05 | 2.29% down | 33% up | ||
| 56 | GSKGSK · Health Care | 0.81% | SAR 359.5B | SAR 179.37 | 1.56% down | 5% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | SAR 2.41T | SAR 1,002.04 | 2.04% down | 34% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | SAR 414.9B | SAR 172.77 | 2.25% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | SAR 1.07T | SAR 567.23 | 2.57% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | SAR 1.02T | SAR 657.96 | 1.87% down | 1% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | SAR 256.6B | SAR 80.31 | 0.66% up | 51% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which health care pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 health care pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by short interest have a combined market value of SAR 18.61T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Health care pharmaceutical companies by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.